within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M03A_MuscleRelaxantsPeripherallyActingAgents.M03AC02_Gallamine;

model Gallamine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 1.7500000000000002e-06,
    adminDuration = 600,
    adminMass = 40 / 1000000,
    adminCount = 1,
    Vd = 8.999999999999999e-05,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 7.000000000000001e-05,
    k12 = 1.4e-06,
    k21 = 1.4e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Gallamine</td></tr><tr><td>ATC code:</td><td>M03AC02</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>40</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.09</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.5</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Gallamine is a non-depolarizing neuromuscular blocking agent formerly used as a muscle relaxant during anesthesia, especially in surgical procedures. It competitively inhibits acetylcholine at the neuromuscular junction. It is largely obsolete today, replaced by newer agents, and is not commonly used in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients (general population in surgical anesthesia).</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.M.M03AC02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Gallamine;
